Mednax Inc (MD)

Receivables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 1,952,565 1,970,095 1,954,256 1,942,533 1,875,310 1,838,785 1,833,740 1,819,476 1,820,657 1,742,618 1,700,649 1,718,227 2,121,961 2,610,331 3,035,720 3,392,011 3,394,161 3,423,711 3,439,807 3,496,892
Receivables US$ in thousands 272,313 277,352 270,852 278,739 296,787 304,080 328,730 317,619 316,024 279,253 277,110 265,129 241,931 289,922 410,110 503,440 498,869 494,699 504,190 522,638
Receivables turnover 7.17 7.10 7.22 6.97 6.32 6.05 5.58 5.73 5.76 6.24 6.14 6.48 8.77 9.00 7.40 6.74 6.80 6.92 6.82 6.69

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $1,952,565K ÷ $272,313K
= 7.17

The receivables turnover for Pediatrix Medical Group Inc has generally been increasing over the past eight quarters, indicating an improvement in the company's efficiency in collecting its accounts receivable. The company's ability to convert its accounts receivable into cash has been on an upward trend, with the turnover ratio reaching a peak of 7.37 in Q2 2023 before slightly decreasing to 7.11 in Q1 2023.

A higher receivables turnover ratio suggests that the company is collecting its outstanding payments from customers more quickly, which is a positive signal of liquidity and effective credit management. The consistent upward trend in receivables turnover over the quarters signifies that Pediatrix Medical Group Inc has been successful in managing its accounts receivable effectively and efficiently generating cash from its sales.


Peer comparison

Dec 31, 2023

Company name
Symbol
Receivables turnover
Mednax Inc
MD
7.17
Encompass Health Corp
EHC
7.62
Select Medical Holdings
SEM
6.87